5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.83▲ | 7.81▲ | 7.80▲ | 8.04▼ | 8.33▼ |
MA10 | 7.76▲ | 7.73▲ | 7.80▲ | 8.49▼ | 7.80▲ |
MA20 | 7.73▲ | 7.89▼ | 7.93▼ | 8.26▼ | 7.26▲ |
MA50 | 7.90▼ | 8.23▼ | 8.43▼ | 7.44▲ | 8.86▼ |
MA100 | 8.30▼ | 8.57▼ | 8.36▼ | 7.39▲ | 15.47▼ |
MA200 | 8.63▼ | 7.99▼ | 7.79▲ | 8.85▼ | 100.65▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.037▲ | 0.034▲ | 0.020▲ | -0.138▼ | 0.307▲ |
RSI | 52.162▲ | 45.726▼ | 43.040▼ | 47.660▼ | 48.098▼ |
STOCH | 88.874▲ | 55.294 | 33.244 | 22.852 | 68.654 |
WILL %R | -30.645 | -49.000 | -60.769 | -84.120▼ | -39.070 |
CCI | 122.582▲ | 31.390 | -7.685 | -106.129▼ | 46.854 |
Wednesday, June 18, 2025 02:29 PM
THOUSAND OAKS, Calif., May 17, 2025--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...
|
Thursday, March 13, 2025 09:00 AM
Atara Biotherapeutics (ATRA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
|
Friday, February 14, 2025 06:55 AM
Shares of Atara Biotherapeutics (ATRA) have gained 11.4% over the past four weeks to close the last trading session at $8.72, but there could still be a solid upside left in the stock if short ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
23/06/25 | 7.855 | 7.855 | 7.855 | 7.855 | 5,957 |
20/06/25 | 8.05 | 8.05 | 7.51 | 7.94 | 86,859 |
18/06/25 | 7.92 | 8.28 | 7.79 | 8.02 | 71,466 |
17/06/25 | 8.38 | 8.38 | 7.74 | 7.80 | 45,473 |
16/06/25 | 9.00 | 9.00 | 8.32 | 8.58 | 39,434 |
13/06/25 | 8.57 | 8.855 | 8.50 | 8.82 | 34,168 |
12/06/25 | 8.88 | 8.88 | 8.56 | 8.71 | 43,134 |
11/06/25 | 9.1445 | 9.205 | 8.62 | 8.91 | 55,468 |
10/06/25 | 9.33 | 9.33 | 8.90 | 8.98 | 43,723 |
09/06/25 | 9.34 | 9.6825 | 9.0001 | 9.255 | 66,437 |
|
|
||||
|
|
||||
|
|